Aflibercept for diabetic macular oedema: a Meta-analysis of randomized controlled trials
Author:
Corresponding Author:

Chu Luan Nguyen. 901/8 Northcote St, Naremburn, NSW 2065, Australia. chuluannguyen@gmail.com

Affiliation:

Clc Number:

Fund Project:

Supported by the University of Sydney, Sydney, Australia.

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To evaluate the relative efficacy and safety of aflibercept for treatment of diabetic macular oedema (DMO). METHODS: A comprehensive search in MEDLINE, CENTRAL and EMBASE was undertaken for randomized controlled trials (RCTs) comparing intravitreal anti-vascular endothelial growth factor (anti-VEGF) versus another treatment. Primary outcome measures were proportion of patients with at least 15 letters of gain or loss on a logMAR visual acuity chart, and change in best corrected visual acuity (BCVA) and central macular thickness (CMT) from baseline. Safety outcomes were rates of death, thromboembolic events and any systemic or ocular serious adverse events. The final search was performed on November 2017. RESULTS: Four RCTs were included. Only one trial compared efficacy and safety of aflibercept with bevacizumab and ranibizumab over 1 or 2y. Three trials were included for Meta-analysis comprising 661 patients (331 in the aflibercept, and 330 in the photocoagulation group). Aflibercept was more efficacious compared to photocoagulation in the proportion of patients with at least 15 letters of improvement and worsening, and in improvement of BCVA and reduction in CMT at 1 or 2y. The safety estimates at 1 or 2y did not differ statistically. CONCLUSION: Aflibercept offers superior benefits over photocoagulation in improving and preserving vision, with no differences in safety. Further comparative effectiveness trials between aflibercept and other anti-VEGF agents will aid ophthalmologists in treatment decisions.

    Reference
    Related
    Cited by
Get Citation

Chu Luan Nguyen, Andrew Lindsay, Eugene Wong, et al. Aflibercept for diabetic macular oedema: a Meta-analysis of randomized controlled trials. Int J Ophthalmol, 2018,11(6):1002-1008

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:October 10,2017
  • Revised:January 03,2018
  • Adopted:
  • Online: June 12,2018
  • Published: